Science 37 Holdings, Inc.

Science 37 Holdings, Inc., trading on Nasdaq under the ticker SNCE, is a healthcare technology company focused on decentralized clinical trials, enabling pharmaceutical and biotech sponsors to conduct remote and hybrid patient studies. The company went public through a merger with LifeSci Acquisition Corp, a blank-check vehicle sponsored by LifeSci Capital, which completed its IPO in 2020. The 10-Q filed on February 2, 2021, with accession number 0001104659-21-010906, represents a quarterly disclosure submitted ahead of the de-SPAC transaction closing, which was finalized later in 2021. Science 37 operates within the life sciences and clinical research technology sector. Sign up for SpacDesk to access the full data profile, filings history, and analytics for SNCE and hundreds of other SPAC transactions.